Evidence map›Paper›PMID 17417969›Full record

ArticleBMC developmental biology2007

Large-scale RNAi screens identify novel genes that interact with the C. elegans retinoblastoma pathway as well as splicing-related components with synMuv B activity.

Julian Ceron, Jean-François Rual, Abha Chandra, Denis Dupuy, Marc Vidal, Sander van den Heuvel

Open access · hybridAbstract read
In one paragraph

Article in BMC developmental biology, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 86 papers.

0numbers the graph read from it
0cells of the map it votes in
86citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

86 citing papers in PubMed, 127 citations in OpenAlex.

  1. Article
  2. Vitamin BNature communications · 2026
    Article
  3. Gap junctions in the alimentary tract regulate reproductive span inbioRxiv : the preprint server for biology · 2026
    Article
  4. Article
  5. Vitamin BResearch square · 2025
    Article
  6. Article
  7. Unzipping the defense: a comprehensive review on bZIP transcription factors inFrontiers in cellular and infection microbiology · 2025
    Review
  8. Analysis ofComputational and structural biotechnology journal · 2024
    Article
  9. High-resolution reconstruction of aRNA (New York, N.Y.) · 2024
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Pathways that affect anterior morphogenesis inbioRxiv : the preprint server for biology · 2023
    Article
  19. Article
  20. Article

26 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Julian CeronMassachusetts General Hospital Cancer Center and Harvard Medical School, Charlestown, MA 02129, USA. jceron@ir.vhebron.net
Jean-François Rual
Abha Chandra
Denis Dupuy
Marc Vidal
Sander van den Heuvel
Dana-Farber Cancer Institute · USHarvard University · USCenter for Cancer Research · US

Funding

Screen for genes targeted by homozygous deletion during cancer progressionP01CA095281 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI HABER, DANIEL A. · 2002 to 2006
$8.4M
NCI NIH HHS P01 CA095281NCI NIH HHS P01 CA95281
6 · The paper itself

Abstract

backgroundThe retinoblastoma tumor suppressor (Rb) acts in a conserved pathway that is deregulated in most human cancers. Inactivation of the single Rb-related gene in Caenorhabditis elegans, lin-35, has only limited effects on viability and fertility, yet causes changes in cell-fate and cell-cycle regulation when combined with inactivation of specific other genes. For instance, lin-35 Rb is a synthetic multivulva (synMuv) class B gene, which causes a multivulva phenotype when inactivated simultaneously with a class A or C synMuv gene.

resultsWe used the ORFeome RNAi library to identify genes that interact with C. elegans lin-35 Rb and identified 57 genes that showed synthetic or enhanced RNAi phenotypes in lin-35 mutants as compared to rrf-3 and eri-1 RNAi hypersensitive mutants. Based on characterizations of a deletion allele, the synthetic lin-35 interactor zfp-2 was found to suppress RNAi and to cooperate with lin-35 Rb in somatic gonad development. Interestingly, ten splicing-related genes were found to function similar to lin-35 Rb, as synMuv B genes that prevent inappropriate vulval induction. Partial inactivation of specific spliceosome components revealed further similarities with lin-35 Rb functions in cell-cycle control, transgene expression and restricted expression of germline granules.

conclusionWe identified an extensive series of candidate lin-35 Rb interacting genes and validated zfp-2 as a novel lin-35 synthetic lethal gene. In addition, we observed a novel role for a subset of splicing components in lin-35 Rb-controlled processes. Our data support novel hypotheses about possibilities for anti-cancer therapies and multilevel regulation of gene expression.

Indexed as

Genes, HelminthRNA InterferenceAnimalsCaenorhabditis elegansCaenorhabditis elegans ProteinsFemaleGene Expression Regulation, DevelopmentalPhenotypeRepressor ProteinsRetinoblastoma ProteinRNA, Double-StrandedRNA, HelminthSpliceosomesVulvaZinc FingersCaenorhabditis elegans Proteinslin-35 protein, C elegansRepressor ProteinsRetinoblastoma ProteinRNA, Double-StrandedRNA, Helminth

Identifiers

PMID17417969
PMCPMC1863419
OpenAlexW2154340237

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.